Loo CK

Black Dog Institute, University of New South Wales, Australia.

3 papers · ORCID

ArticleKetamine

Effectiveness and safety of repeat dose subcutaneous ketamine for treatment-resistant depression, and the impact of prior ketamine treatment: open label extension of the KADS study.

Glozier N, Morris R, Stratton E +21

Europe PMC2026
ArticlePsilocybin

Improving access to novel treatments for treatment-resistant depression: The potential role of specialist clinics in Australia.

Giri Y, Furst P, Loo CK +2

Europe PMC2026
ArticleKetamine

A systematic review of the print media representation of ketamine treatments for psychiatric disorders.

Thornton NLR, Kawalsky J, Milton A +5

Europe PMC2023